These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 19603590)

  • 1. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
    Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
    Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging.
    Sadan O; Shemesh N; Barzilay R; Bahat-Stromza M; Melamed E; Cohen Y; Offen D
    Stem Cells; 2008 Oct; 26(10):2542-51. PubMed ID: 18635865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.
    Sadan O; Shemesh N; Barzilay R; Dadon-Nahum M; Blumenfeld-Katzir T; Assaf Y; Yeshurun M; Djaldetti R; Cohen Y; Melamed E; Offen D
    Exp Neurol; 2012 Apr; 234(2):417-27. PubMed ID: 22285250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease.
    Sadan O; Bahat-Stromza M; Barhum Y; Levy YS; Pisnevsky A; Peretz H; Ilan AB; Bulvik S; Shemesh N; Krepel D; Cohen Y; Melamed E; Offen D
    Stem Cells Dev; 2009 Oct; 18(8):1179-90. PubMed ID: 19243240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
    Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells.
    Pineda JR; Rubio N; Akerud P; Urbán N; Badimon L; Arenas E; Alberch J; Blanco J; Canals JM
    Gene Ther; 2007 Jan; 14(2):118-28. PubMed ID: 16943855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain.
    Moloney TC; Rooney GE; Barry FP; Howard L; Dowd E
    Brain Res; 2010 Nov; 1359():33-43. PubMed ID: 20732313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
    Blandini F; Cova L; Armentero MT; Zennaro E; Levandis G; Bossolasco P; Calzarossa C; Mellone M; Giuseppe B; Deliliers GL; Polli E; Nappi G; Silani V
    Cell Transplant; 2010; 19(2):203-17. PubMed ID: 19906332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease.
    Dey ND; Bombard MC; Roland BP; Davidson S; Lu M; Rossignol J; Sandstrom MI; Skeel RL; Lescaudron L; Dunbar GL
    Behav Brain Res; 2010 Dec; 214(2):193-200. PubMed ID: 20493905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.
    Cova L; Armentero MT; Zennaro E; Calzarossa C; Bossolasco P; Busca G; Lambertenghi Deliliers G; Polli E; Nappi G; Silani V; Blandini F
    Brain Res; 2010 Jan; 1311():12-27. PubMed ID: 19945443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
    Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
    Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
    Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
    Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
    Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
    J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.
    Garbayo E; Montero-Menei CN; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
    J Control Release; 2009 Apr; 135(2):119-26. PubMed ID: 19154763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro.
    Jin GZ; Cho SJ; Choi EG; Lee YS; Yu XF; Choi KS; Yee ST; Jeon JT; Kim MO; Kong IK
    Cell Biol Int; 2008 Nov; 32(11):1433-8. PubMed ID: 18778785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia.
    Jones J; Jaramillo-Merchán J; Bueno C; Pastor D; Viso-León M; Martínez S
    Neurobiol Dis; 2010 Nov; 40(2):415-23. PubMed ID: 20638477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Growth factors as neuroprotective treatment in Parkinson disease?].
    Torp R; Singh PB; Sørensen DR; Dietrichs E; Hirschberg H
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):899-901. PubMed ID: 16554879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
    Rossignol J; Boyer C; Lévèque X; Fink KD; Thinard R; Blanchard F; Dunbar GL; Lescaudron L
    Behav Brain Res; 2011 Mar; 217(2):369-78. PubMed ID: 21070819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.